Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December 2012 Volume 4 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December 2012 Volume 4 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients

  • Authors:
    • Sang Hyub Lee
    • Joong Geun Lee
    • Gyeong Eun Min
    • Hyung‑Lae Lee
    • Choong Hyun Lee
    • Koo Han Yoo
  • View Affiliations / Copyright

    Affiliations: Department of Urology, School of Medicine, Kyung Hee University, Seoul 134‑727, Republic of Korea
  • Pages: 1112-1116
    |
    Published online on: September 14, 2012
       https://doi.org/10.3892/etm.2012.708
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Detrusor overactivity (DO) with impaired contractility (DOIC) is a mixed pattern of involuntary contraction and increased post‑void residual urine volume (PVR) which occurs in stroke patients. Urodynamic study results obtained from patients with detrusor abnormalities and stroke were analyzed to identify the associations between various urodynamic parameters and DOIC. Between August 2003 and November 2010, 127 patients were selected from 178 patients undergoing urodynamic study due to urinary symptoms. Stroke patients were divided into three groups: the DO, DOIC and detrusor underactivity (DU) groups. The significance of differences between the three groups was analyzed using the Kruskal‑Wallis test and receiver operating characteristic (ROC) curves were used to calculate the accuracy of the urodynamic study result factors to distinguish between the three groups. The average total bladder capacity (TBC) was 219.15±98.30 ml in the DO, 330.25±115.75 ml in the DOIC and 486.00±111.48 ml in the DU (P<0.001) group. The average PVR was 22.64±20.85 ml in the DO, 146.87±95.09 ml in the DOIC and 425.33±136.70 ml in the DU (P<0.001) group. A ROC curve of DO and DOIC revealed that TBC and PVR were significantly different between the DOIC and DO groups. The area under the curve (AUC) of TBC was 0.812 (P<0.001) and that of PVR was 0.987 (P<0.001). A ROC curve of DOIC and DU revealed that TBC and PVR were significantly different between the DOIC and DU groups. The AUC of TBC was 0.813 (P<0.001) and that of PVR was 0.929 (P<0.001). In the urodynamic study of stroke patients with urinary symptoms, TBC and PVR may provide useful information for treating patients who cannot undergo urodynamic study.

Introduction

Stroke is one of the most serious events that affects the elderly population. Stroke patients suffer impairment, including the loss of memory, vision, speech, motor function and voiding control (1). A number of stroke patients suffer from lower urinary tract symptoms (LUTS) that include frequency, urgency, urge incontinence, dysuria and urinary retention (2). Untreated voiding symptoms may have a major negative impact on the quality of life of stroke patients and their relatives and are associated with a high mortality risk (3–5). LUTS are important to urologists and it is essential to evaluate detrusor function to manage LUTS in stroke patients (6).

The majority of common urinary symptoms in stroke patients are storage symptoms, such as nocturia, urgency, frequency and urge incontinence. However, certain patients complain of voiding symptoms such as strain, weak stream and tenesmus (6). Stroke patients may experience storage and voiding symptoms together (7). When these symptoms occur together it is termed detrusor overactivity (DO) with impaired contractility (DOIC). DOIC is complicated to manage and presents a challenging clinical problem (8). Stroke patients with LUTS should undergo urodynamic study to evaluate their detrusor function, particularly when the patient has urgency, urge incontinence, weak stream or tenesmus. However, urodynamic examination of stroke patients is a difficult task due to their poor condition or inability to cooperate.

In the present study, the urodynamic characteristics of patients with detrusor abnormalities and stroke were retrospectively analyzed to ascertain how total bladder capacity (TBC) and post-void residual urine volume (PVR) were reflected in diagnosing DOIC. The aim of the present study was to develop a simple method for detecting DOIC.

Patients and methods

Patients

Between August 2003 and November 2010, 178 stroke patients underwent urodynamic study due to LUTS. A total of 51 patients were excluded due to prostate volumes >35 ml on transrectal ultrasonography, poorly controlled diabetes, bladder outlet obstruction, detrusor-external urethra sphincter dyssynergia or normal findings on urodynamic study. Informed consent was obtained from all patients.

Urodynamic studies

The urodynamic studies were performed using the Libra urodynamic test system (Medical Measurement Systems, Enschede, The Netherlands) (6). All patients were cooperative and free of any urological medications, such as antimuscarinic agents or α-blockers, which may have affected the test. Each patient was supine for a check that the bladder was empty prior to performing the tests. An 8-French double lumen catheter was inserted into the bladder via the urethra to fill the bladder and measure the bladder pressure. The bladder was filled with room temperature sterile saline at a rate of 30 ml/min. Intravesical pressures were checked during all the tests. As saline flushing of the bladder proceeded, each patient was asked if they had a desire to urinate. The points of the patients' first, normal and strong desire to urinate were recorded. Filling of the bladder was stopped when the desire to urinate was strong and represented the cystometric capacity. When filling was complete, the patients were requested to urinate. Urodynamic parameters, including TBC, PVR, voided volume (VV), peak flow rate (Qmax), average flow rate (Qavg), compliance and detrusor pressure at peak flow rate (PdetQmax) were measured.

Patients were divided into three groups according to the results. The detrusor underactivity (DU) group was defined as voiding with abdominal pressure instead of detrusor contraction, residual urine volume >50 ml or an inability to void (9,10). The DO group included patients who exhibited involuntary detrusor contraction during the filling phase (2). The third group was the DOIC group. Since the diagnostic criteria of DOIC have not been confirmed by the International Continence Society (ICS), DOIC was defined as the presence of involuntary contraction during the filling phase and under-active detrusor function during voiding phase, voiding with abdominal pressure only or residual urine >50 ml (2,9,10).

Statistical analysis

The significance of differences between the three groups was analyzed using the Kruskal-Wallis test. The baseline characteristics and urodynamic parameters of each group were compared. Receiver operating characteristic (ROC) curves were drawn to clarify which parameters best aided in determining the status of DOIC. P<0.05 was considered to indicate a statistically significant result.

Results

Patients

Of the 127 patients, 57 were male and 70 were female. The basic characteristics of each group are shown in Table I. The patient numbers of the DO, DOIC and DU groups were 58 (45.6%), 16 (12.5%) and 53 (41.7%), respectively, and the mean ages were 64.13, 67.13 and 67.90 years, in the same respective order. Comparing male and female patients did not reveal any significant differences. Furthermore, there was no correlation between a patient's gender and neurogenic bladder type. No significant differences were observed among the three groups in the mean interval between the stroke event and the test.

Table I

Baseline characteristics of study population.

Table I

Baseline characteristics of study population.

CharacteristicDODOICDUP-value
Number of patients (%)58 (45.6)16 (12.5)53 (41.7)
Age (years), mean (range)64.13 (23–87)67.31 (51–79)67.90 (45–83)0.420
Interval (months), mean (±SD)13.95±27.849.31±16.0321.32±47.300.506

[i] DO, detrusor overactivity; DOIC, detrusor overactivity with impaired contractility; DU, detrusor underactivity. There were 127 patients, of whom 57 were male and 70 were female.

Urodynamic studies

When DOIC was compared with DO, the two groups demonstrated significant differences in TBC and PVR. The urodynamic factors of the two groups are shown in Table II. The average TBCs of the DO and DOIC groups were 219.15±98.30 and 330.25±115.75 ml, respectively. The average PVRs of the DO and DOIC groups were 22.64±20.85 and 146.87±95.09 ml, respectively. The differences between the two groups were significant (P<0.001). However, no significant differences were observed for the other factors. The average VV of each group was 196.67±101.46 (DO) and 185.87±108.48 ml (DOC; P=0.724). The other urodynamic factors, including Qmax, Qavg, compliance and PdetQmax, were not observed to be significantly different between the two groups.

Table II

Urodynamic factors of the DO and DOIC groups. TBC and PVR were the only factors which had significant differences between the two groups.

Table II

Urodynamic factors of the DO and DOIC groups. TBC and PVR were the only factors which had significant differences between the two groups.

FactorDO, mean ± SDDOIC, mean ± SDP-value
TBC (ml)219.15±98.30330.25±115.750.002
VV (ml)196.67±101.46185.87±108.480.724
PVR (ml)22.64±20.85146.87±95.09<0.001
Qmax (ml/sec)15.12±9.9811.95±6.660.152
Qavg (ml/sec)6.74±3.805.28±3.190.142
Compliance25.18±72.4316.98±23.460.498
PdetQmax (ml/sec)41.05±24.1230.00±10.590.011

[i] DO, detrusor overactivity; DOIC, detrusor overactivity with impaired contractility; TBC, total bladder capacity; VV, voiding volume; PVR, post-void residual volume; Qmax, peak flow rate; Qavg, average flow rate; PdetQmax, detrusor pressure at peak flow rate.

Similar results were revealed by the ROC curve of DOIC and DO. Fig. 1 shows a ROC curve of DOIC and DO. The area under the curve (AUC) of TBC was 0.812 (P<0.001) and that of PVR was 0.987 (P<0.001). However, the AUC of VV was 0.474 and those of Qmax, Qavg and PdetQmax were 0.421, 0.591 and 0.369, respectively. Only TBC and PVR were significantly different and clinically useful factors for distinguishing DOIC from DO. Compared with the DO group, if the cut-off value of TBC in the DOIC group was set to >262.50 ml, the sensitivity was 90.9% and the specificity was 68.4%. If the cut-off value of PVR in the DOIC group was set to >67.50 ml then the sensitivity was 90.9% and the specificity was 94.7%.

Figure 1

Receiver operating characteristic curve of detrusor overactivity group and detrusor hyperactivity with impaired contractility group. TBC, total bladder capacity; VV, voiding volume; PVR, post-void residual volume; Qmax, peak flow rate; Qavg, average flow rate; PdetQmax, detrusor pressure at peak flow rate.

By contrast, the DOIC and DU groups demonstrated significant differences in all urodynamic factors. The factors of the two groups are presented in Table III. The average TBCs of the DOIC and DU groups were 330.25±115.75 and 486.00±111.48 ml (P<0.001), respectively. The average PVRs of the DOIC and DU groups were 146.87±95.09 and 425.33±136.70 ml, respectively, and the difference between the two groups was significant (P<0.001). The average VVs of the two groups were 185.87±108.48 (DOIC) and 63.94±109.30 ml (DU) and were significantly different (P= 0.001). The other urodynamic factors, including Qmax, Qavg, compliance and PdetQmax also exhibited significant differences between the two groups.

Table III

Urodynamic factors of the DU and DOIC groups. All urodynamic factors had significant differences between the two groups.

Table III

Urodynamic factors of the DU and DOIC groups. All urodynamic factors had significant differences between the two groups.

FactorDU, mean ± SDDOIC, mean ± SDP-value
TBC (ml)486.00±111.48330.25±115.75<0.001
VV (ml)63.94±109.30185.87±108.480.001
PVR (ml)425.33±136.70146.87±95.09<0.001
Qmax (ml/sec)3.43±5.2311.95±6.660.003
Qavg (ml/sec)1.66±2.515.28±3.190.010
Compliance139.04±206.6016.98±23.460.002
PdetQmax (ml/sec)10.56±15.0730.00±10.590.001

[i] DOIC, detrusor overactivity with impaired contractility; DU, detrusor underactivity; TBC, total bladder capacity; VV, voiding volume; PVR, post-void residual volume; Qmax, peak flow rate; Qavg, average flow rate; PdetQmax, detrusor pressure at peak flow rate.

Fig. 2 presents a ROC curve of DOIC and DU. TBC and PVR were significantly different between the DOIC and DU groups. The AUC of TBC was 0.813 (P<0.001) and that of PVR was 0.929 (P<0.001). The cut-off value was also determined. Compared with the DU group, if the cut-off value of TBC in the DOIC group was set to <335 ml, the sensitivity was 90.3% and the specificity was 72.7%. If the cut-off value of PVR in the DOIC group was set to <220 ml then the sensitivity was 90.3% and the specificity was 81.8%.

Figure 2

Receiver operating characteristic curve of detrusor hyperactivity with impaired contractility group and detrusor overactivity group. TBC, total bladder capacity; VV, voiding volume; PVR, post-void residual volume; Qmax, peak flow rate; Qavg, average flow rate; PdetQmax, detrusor pressure at peak flow rate.

TBC and PVR were the only factors that were able to distinguish DOIC from DO and DU. The TBC and PVR of the DOIC group were greater than those of the DO group but smaller than those of the DU group. Therefore, the ranges of TBC and PVR were useful for diagnosing DOIC using the ROC curves. If the TBC and PVR of patients with LUTS were 262.5–335 and 67.5–220 ml, respectively, DOIC may be predicted.

Discussion

Since the first description of patients with DOIC, numerous studies concerning DOIC have been published (8,11). The reported criteria for DOIC are a combination of urodynamically proven urgency or urge incontinence and a high PVR. In the present study, DOIC was defined more strictly urodynamically in terms of using abdominal pressure instead of detrusor contraction in voiding or a PVR of over 50 ml, indicating impaired contractile function (9,10). The present urodynamic criteria for DOIC yielded clinical results that did not differ from those of previous studies (8,11).

The high prevalence of LUTS, including urinary incontinence, in stroke patients has been reported previously (12,13). Incontinence may persist for months following the event (3). Stroke patients with urinary incontinence have a higher risk of mortality than stroke patients who are not incontinent. Urinary incontinence in stroke patients has a significant impact on their lives, frequently including greater morbidity and mortality (14,15). However, the previously mentioned studies noted that not only urinary incontinence but also other urinary tract symptoms, such as nocturia, frequency, urgency, pain and straining affect quality of life. Two studies reported all the possible urinary symptoms of stroke patients (14,15). These studies focused not only on urge incontinence but also frequency, nocturia and straining (3,14,15). Tibaek et al reported that at least one LUTS may bother stroke patients (16). In the present study, the most frequent symptom in females and males was nocturia (76% for both) followed by urgency (70 and 61%, respectively). Furthermore, 60% of all patients (51% females, 67% males) suffered from voiding symptoms such as weak stream, hesitancy, incomplete emptying or straining.

Few studies have mentioned the association between stroke and DOIC. Yamamoto et al suggested that numerous neurological diseases cause DOIC and that multiple cerebral infarction (MCI) is one cause of DOIC (7). The authors reported that 9 of 70 (12%) MCI patients had DOIC. However, the authors noted that the study did not consider and examine a combination of multiple diseases, such as MCI and diabetic cystopathy. Tibaek et al reported that stroke may affect the patients' voiding symptoms, precluding the development of a variety of LUTS (16). The authors surveyed 482 stroke patients and noted both storage and voiding symptoms in 43% of this population. Although the authors did not perform a urodynamic study and instead gathered information solely by a questionnaire, it appears likely that at least some of these patients with both symptoms had DOIC. The design of the present study enabled the determination of the presence of storage and voiding symptoms in DOIC patients.

Previously, we were able to evaluate the bladder function of stroke patients by the type of stroke (6) and concluded that an evaluation of the stroke type is likely to aid the determination of the type of urinary dysfunction and in deciding the appropriate bladder management. However, we observed no significant differences in LUTS between dominant, non-dominant and bilateral hemispheric ischemic stroke patients (17). It has been argued that despite problems in elderly patients, it is reasonable to perform complex urodynamic studies (18). The collective results favor the suggestion that urodynamic examination is necessary for stroke patients with LUTS to understand detrusor function and manage voiding symptoms.

Diagnosis and management of DOIC are difficult. Empirical prescription of anticholinergic agents may lead to acute urinary retention and α-blockers may aggravate incontinent urgency (8). To manage DOIC, precise knowledge of detrusor function is necessary. The common criteria for DOIC are involuntary contraction during the filling phase and no detrusor contraction during the voiding phase or a high PVR. Studies that have urodynamically defined DOIC have concluded that this strategy is necessary for a diagnosis of DOIC. However, this strategy is challenging for stroke patients with DOIC who cannot cooperate with the examiner in expressing their intention or whose urine analysis reveals consistent pyuria. Problems unique to the evaluation of elderly patients with stroke include technical difficulties in interpreting urodynamic results (8). Consequently, if there was an easy method for predicting DOIC, clinicians may choose this method for stroke patients whose cooperation is difficult to achieve.

In the present study, the DU, DOIC and DO groups revealed significant differences in all urodynamic factors which may reflect different characteristics of the groups. In ROC curve analysis, TBC and PVR were significant factors for distinguishing DOIC from DU or DO. Checking TBC and PVR may aid clinicians in the diagnosis of DOIC. By determining the cut-off value, DOIC may be predicted when TBC is 262.5–335 ml and PVR is 67.5–220 ml.

To clarify the criteria and definition of DOIC, further functional studies are required. Since there is no easy method to diagnose DOIC, urodynamic examination is an inevitable test for patients with storage and emptying symptoms. However, in patients for whom urodynamic information cannot be easily obtained, the evaluation of TBC and PVR may be useful for the determination of DOIC and bladder management. TBC and PVR data may be used to predict whether stroke patients in poor condition have DOIC.

In conclusion, evaluation of TBC and PVR may be useful for diagnosing DOIC in stroke patients who cannot undergo urodynamic study. DOIC may be predicted when TBC and PVR are within target ranges.

References

1 

Marinkovic SP and Badlani G: Voiding and sexual dysfunction after cerebrovascular accidents. J Urol. 165:359–370. 2001. View Article : Google Scholar : PubMed/NCBI

2 

Abrams P, Cardozo L, Fall M, et al: Standardisation Sub-committee of the International Continence Society: The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 21:167–178. 2002. View Article : Google Scholar

3 

Brittain KR, Perry SI, Peet SM, et al: Prevalence and impact of urinary symptoms among community-dwelling stroke survivors. Stroke. 31:886–891. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Tilvis RS, Hakala SM, Valvanne J and Erkinjuntti T: Urinary incontinence as a predictor of death and institutionalization in a general aged population. Arch Gerontol Geriatr. 21:307–315. 1995. View Article : Google Scholar : PubMed/NCBI

5 

Campbell AJ, Reinken J and McCosh L: Incontinence in the elderly: prevalence and prognosis. Age Ageing. 14:65–70. 1985. View Article : Google Scholar : PubMed/NCBI

6 

Han KS, Heo SH, Lee SJ, et al: Comparison of urodynamics between ischemic and hemorrhagic stroke patients; can we suggest the category of urinary dysfunction in patients with cerebrovascular accident according to type of stroke? Neurourol Urodyn. 29:387–390. 2010.

7 

Yamamoto T, Sakakibara R, Uchiyama T, et al: Neurological diseases that cause detrusor hyperactivity with impaired contractile function. Neurourol Urodyn. 25:356–360. 2006. View Article : Google Scholar : PubMed/NCBI

8 

Griffiths DJ, McCracken PN, Harrison GM, et al: Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn. 21:126–131. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Abdel-Rahman M, Coulombe A, Devroede G, et al: Urorecto-dynamic evaluation of healthy volunteers. Urology. 19:559–564. 1982. View Article : Google Scholar : PubMed/NCBI

10 

Robertson AS, Griffiths CJ, Ramsden PD and Neal DE: Bladder function in healthy volunteers: ambulatory monitoring and conventional urodynamic studies. Br J Urol. 73:242–249. 1994. View Article : Google Scholar : PubMed/NCBI

11 

Resnick NM and Yalla SV: Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA. 257:3076–3081. 1987. View Article : Google Scholar : PubMed/NCBI

12 

Brittain KR, Peet SM and Castleden CM: Stroke and incontinence. Stroke. 29:524–528. 1998. View Article : Google Scholar

13 

Gelber DA, Good DC, Laven LJ and Verhulst SJ: Causes of urinary incontinence after acute hemispheric stroke. Stroke. 24:378–382. 1993. View Article : Google Scholar : PubMed/NCBI

14 

Barer DH: Continence after stroke: useful predictor or goal of therapy? Age Ageing. 18:183–191. 1989. View Article : Google Scholar : PubMed/NCBI

15 

Gariballa SE: Potentially treatable causes of poor outcome in acute stroke patients with urinary incontinence. Acta Neurol Scand. 107:336–340. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Tibaek S, Gard G, Klarskov P, et al: Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn. 27:763–771. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Kim TG, Yoo KH, Jeon SH, et al: Effect of dominant hemispheric stroke on detrusor function in patients with lower urinary tract symptoms. Int J Urol. 17:656–660. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Resnick NM, Yalla SV and Laurino E: The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med. 320:1–7. 1989. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lee SH, Lee JG, Min GE, Lee HL, Lee CH and Yoo KH: Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients. Exp Ther Med 4: 1112-1116, 2012.
APA
Lee, S.H., Lee, J.G., Min, G.E., Lee, H., Lee, C.H., & Yoo, K.H. (2012). Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients. Experimental and Therapeutic Medicine, 4, 1112-1116. https://doi.org/10.3892/etm.2012.708
MLA
Lee, S. H., Lee, J. G., Min, G. E., Lee, H., Lee, C. H., Yoo, K. H."Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients". Experimental and Therapeutic Medicine 4.6 (2012): 1112-1116.
Chicago
Lee, S. H., Lee, J. G., Min, G. E., Lee, H., Lee, C. H., Yoo, K. H."Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients". Experimental and Therapeutic Medicine 4, no. 6 (2012): 1112-1116. https://doi.org/10.3892/etm.2012.708
Copy and paste a formatted citation
x
Spandidos Publications style
Lee SH, Lee JG, Min GE, Lee HL, Lee CH and Yoo KH: Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients. Exp Ther Med 4: 1112-1116, 2012.
APA
Lee, S.H., Lee, J.G., Min, G.E., Lee, H., Lee, C.H., & Yoo, K.H. (2012). Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients. Experimental and Therapeutic Medicine, 4, 1112-1116. https://doi.org/10.3892/etm.2012.708
MLA
Lee, S. H., Lee, J. G., Min, G. E., Lee, H., Lee, C. H., Yoo, K. H."Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients". Experimental and Therapeutic Medicine 4.6 (2012): 1112-1116.
Chicago
Lee, S. H., Lee, J. G., Min, G. E., Lee, H., Lee, C. H., Yoo, K. H."Usefulness of total bladder capacity and post‑void residual urine volume as a predictor of detrusor overactivity with impaired contractility in stroke patients". Experimental and Therapeutic Medicine 4, no. 6 (2012): 1112-1116. https://doi.org/10.3892/etm.2012.708
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team